Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BY 4.0Nanomaterials

A Review of Antimicrobial Mechanisms of Graphene Oxide, Reduced Graphene Oxide, and Graphene Nanoplatelets: Implications for Polymer-Based Dental Materials

  1. 1Faculdade de Medicina Dentária, Universidade do Porto, Rua Dr. Manuel Pereira da Silva, 4200-393 Porto, Portugal
  2. 2Instituto de Ciência e Inovação em Engenharia Mecânica e Engenharia Industrial (INEGI), Universidade do Porto, Campus da FEUP, R. Dr. Roberto Frias 400, 4200-465 Porto, Portugal

Abstract

Graphene-based materials, including graphene oxide (GO), reduced graphene oxide (rGO), and graphene nanoplatelets (GNPs), exhibit a relatively large surface area and tunable surface chemistry, enabling diverse biological interactions. These interactions depend on oxygen-containing functional groups, oxidation degree, lateral size, and surface charge. In dental materials, these properties support incorporation of graphene-based materials into polymer matrices to reduce microbial adhesion, inhibit biofilm formation, and limit infection-related degradation. This review critically evaluates GO, rGO, and GNPs in polymer-based dental materials, focusing on structure–property–biological response relationships and antimicrobial performance. Current evidence indicates that GO demonstrates the most consistent antibacterial and antifungal activity, mainly due to its high density of functional groups and hydrophilicity. In contrast, rGO and GNPs show more variable or moderate antimicrobial effects, often requiring surface modification, optimized composite design, or higher material loading. Here, key limitations affecting clinical application are also discussed. Several biological effects are concentration-dependent, including human cytotoxicity, host enzyme interactions, potential immune responses, long-term biocompatibility, and stability under oral conditions. By integrating mechanistic insights across graphene-based materials, this review clarifies their potential and current limitations for polymeric dental applications and identifies priorities supporting the transition from laboratory-scale research to clinical and industrial implementation strategies.

Related

  1. Production and thermal performance evaluation of graphene nanoplatelets/Al₂O₃-reinforced Al6061–Cu hybrid thermal interface material
    Surrya Prakash DilliBabu, Naveen Kilari, Grandhamala Sravanthi +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Materials & polymersCrossref
  2. Epoxy and Vinyl Silane Functionalization of Graphene Nanoplatelets
    Myles T. Blurton, Marc Walker, Fengzai Tang +3
    ACS OmegaPeer-reviewedCC BY 4.0Full textGeneral chemistryCrossref
  3. Review on mechanisms, applications, and research progress of externally tunable and green manufacturing flexible sensors based on graphene-like materials
    Ren Jian, Lu Xu, Liu Bin +2
    Nanotechnology ReviewsPeer-reviewedCC BYFull textMaterials & polymersDOAJ
  4. Concentration-dependent nitrogen functionalization of graphene nanoplatelets: structural, surface, and electrical properties
    Rashida Huseynzade, Mustafa Muradov, Sevinj Hamidova +9
    RSC advancesPeer-reviewedCC BYFull textMaterials & polymersEurope PMCPMC
  5. Surface modification strategies for carbon nanotubes and graphene materials: advances in electrochemical catalysis
    Tahir Ahmad Mir, Bonito Aristide Karamoko, Quentin Lenne +1
    Current Opinion in ElectrochemistryPeer-reviewedCC BY-NC-SA 4.0Full textElectrochemistry & energyHAL
BibTeX
@article{cortereal2026review,
  title = {{A Review of Antimicrobial Mechanisms of Graphene Oxide, Reduced Graphene Oxide, and Graphene Nanoplatelets: Implications for Polymer-Based Dental Materials}},
  author = {Inês Côrte-Real and Driss Belayach and Ricardo Martuci and João Sampaio-Fernandes and Maria Helena Figueiral},
  journal = {Nanomaterials},
  year = {2026},
  month = oct,
  doi = {10.3390/nano16211342},
  url = {https://www.mdpi.com/2079-4991/16/21/1342},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A Review of Antimicrobial Mechanisms of Graphene Oxide, Reduced Graphene Oxide, and Graphene Nanoplatelets: Implications for Polymer-Based Dental Materials
AU  - Inês Côrte-Real
AU  - Driss Belayach
AU  - Ricardo Martuci
AU  - João Sampaio-Fernandes
AU  - Maria Helena Figueiral
PY  - 2026
DA  - 2026/10/23
JO  - Nanomaterials
DO  - 10.3390/nano16211342
UR  - https://www.mdpi.com/2079-4991/16/21/1342
AB  - Graphene-based materials, including graphene oxide (GO), reduced graphene oxide (rGO), and graphene nanoplatelets (GNPs), exhibit a relatively large surface area and tunable surface chemistry, enabling diverse biological interactions. These interactions depend on oxygen-containing functional groups, oxidation degree, lateral size, and surface charge. In dental materials, these properties support incorporation of graphene-based materials into polymer matrices to reduce microbial adhesion, inhibit biofilm formation, and limit infection-related degradation. This review critically evaluates GO, rGO, and GNPs in polymer-based dental materials, focusing on structure–property–biological response relationships and antimicrobial performance. Current evidence indicates that GO demonstrates the most consistent antibacterial and antifungal activity, mainly due to its high density of functional groups and hydrophilicity. In contrast, rGO and GNPs show more variable or moderate antimicrobial effects, often requiring surface modification, optimized composite design, or higher material loading. Here, key limitations affecting clinical application are also discussed. Several biological effects are concentration-dependent, including human cytotoxicity, host enzyme interactions, potential immune responses, long-term biocompatibility, and stability under oral conditions. By integrating mechanistic insights across graphene-based materials, this review clarifies their potential and current limitations for polymeric dental applications and identifies priorities supporting the transition from laboratory-scale research to clinical and industrial implementation strategies.
SN  - 2079-4991
ER  -